PACS Group, Inc. (PACS) Stock Forecast
PACS analyst forecast
as of October 18, 2026- Analyst consensus
- Strong buy 4.67 / 5 from 6 analysts
- Price target
- $59.00 average of analyst targets
- Upside to target
- +25.8% from the latest close
- Next earnings
- November 18, 2026 EPS estimate $0.56
- 52-week range
- $10.58 – $48.45
PACS analyst ratings
6 analystsNumber of analysts at each rating.
PACS price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
PACS earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.58 | $0.55 | $0.64 | $0.45 | +28.9% | 5 |
| Current fiscal year (2026) | $2.50 | $2.39 | $2.73 | $1.81 | +38.5% | 5 |
| Next fiscal year (2027) | $2.74 | $2.58 | $3.02 | $2.50 | +9.3% | 5 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
PACS revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.46B | $1.44B | $1.47B | +8.4% | 6 |
| Current fiscal year (2026) | $5.85B | $5.79B | $5.95B | +10.6% | 6 |
| Next fiscal year (2027) | $6.54B | $6.19B | $7.19B | +11.8% | 6 |
PACS EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
PACS revenue: reported and forecast
PACS EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.55 | $0.60 | $0.60 | $0.60 | $0.58 | +6.6% | 3 up · 0 down |
| Current fiscal year (2026) | $2.32 | $2.52 | $2.52 | $2.52 | $2.50 | +7.8% | 4 up · 0 down |
| Next fiscal year (2027) | $2.45 | $2.71 | $2.71 | $2.71 | $2.74 | +11.9% | 4 up · 0 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
PACS earnings surprises
Reported EPS vs the consensus estimate for the last 10 quarters; PACS beat in 7 of 10.
What analysts expect from PACS
6 analysts cover PACS; their consensus rating is strong buy (4.67 on a 1–5 scale, where 5 is a strong buy). The average price target is $59.00, 25.8% above the latest close of $46.91. Analysts expect earnings of $2.50 per share for 2026, +38.5% from a year earlier. For 2027 the average estimate is $2.74 per share on revenue of $6.5 billion. PACS beat the EPS estimate in 7 of the last 10 quarters.
Related: PACS income statement, PACS key metrics, PACS chart. See the PACS stock overview for the latest quote and news.
PACS forecast FAQ
What is PACS's price target?
The average analyst price target for PACS is $59.00, 25.8% above the latest close of $46.91.
Is PACS a buy, hold or sell?
Of 6 analysts covering PACS, 4 rate it a strong buy, 2 a buy, 0 a hold, 0 a sell and 0 a strong sell, a consensus of strong buy. Ratings are opinions, not a recommendation from Quotelinks.
What is PACS's EPS forecast?
Analysts forecast $2.50 per share for 2026 (range $2.39 to $2.73); for 2027 the estimate is $2.74.
What is PACS's revenue forecast?
The average revenue estimate for 2026 is $5.9 billion, growth of 10.6%; for 2027 it is $6.5 billion.
When does PACS report earnings?
PACS is expected to report results for the quarter ending September 30, 2026 on November 18, 2026; the EPS estimate is $0.56.
Does PACS usually beat earnings estimates?
PACS reported EPS at or above the analyst estimate in 7 of the last 10 quarters.